These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25329392)

  • 1. Distribution of CYP2D6 alleles and phenotypes in the Brazilian population.
    Friedrich DC; Genro JP; Sortica VA; Suarez-Kurtz G; de Moraes ME; Pena SD; dos Santos AK; Romano-Silva MA; Hutz MH
    PLoS One; 2014; 9(10):e110691. PubMed ID: 25329392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians.
    Kohlrausch FB; Gama CS; Lobato MI; Belmonte-de-Abreu P; Gesteira A; Barros F; Carracedo A; Hutz MH
    Pharmacogenomics; 2009 Sep; 10(9):1457-66. PubMed ID: 19761369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and linkage disequilibrium of the enhancer SNP rs5758550 among Latin American populations: influence of continental ancestry.
    Elias ABR; Araújo GS; de Souza SJ; Suarez-Kurtz G
    Pharmacogenet Genomics; 2020 Jun; 30(4):67-72. PubMed ID: 32187157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.
    Luo HR; Aloumanis V; Lin KM; Gurwitz D; Wan YJ
    Am J Pharmacogenomics; 2004; 4(6):395-401. PubMed ID: 15651900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
    Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J
    Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses.
    Varela N; Quiñones LA; Stojanova J; Garay J; Cáceres D; Cespedes S; Sasso J; Miranda C
    Pharmacol Res; 2015 Nov; 101():124-9. PubMed ID: 26211952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.
    LLerena A; Naranjo ME; Rodrigues-Soares F; Penas-LLedó EM; Fariñas H; Tarazona-Santos E
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1569-83. PubMed ID: 25316321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.
    Céspedes-Garro C; Jiménez-Arce G; Naranjo ME; Barrantes R; Llerena A;
    Rev Biol Trop; 2014 Dec; 62(4):1659-71. PubMed ID: 25720195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population.
    Rideg O; Háber A; Botz L; Szücs F; Várnai R; Miseta A; Kovács GL
    Cell Biochem Funct; 2011 Oct; 29(7):562-8. PubMed ID: 21826689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.
    Bagheri A; Kamalidehghan B; Haghshenas M; Azadfar P; Akbari L; Sangtarash MH; Vejdandoust F; Ahmadipour F; Meng GY; Houshmand M
    Drug Des Devel Ther; 2015; 9():2627-34. PubMed ID: 25999696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study.
    Dodgen TM; Hochfeld WE; Fickl H; Asfaha SM; Durandt C; Rheeder P; Drögemöller BI; Wright GE; Warnich L; Labuschagne CD; van Schalkwyk A; Gaedigk A; Pepper MS
    BMC Med Genet; 2013 Jan; 14():20. PubMed ID: 23356658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.
    Panserat S; Sica L; Gérard N; Mathieu H; Jacqz-Aigrain E; Krishnamoorthy R
    Br J Clin Pharmacol; 1999 Jan; 47(1):121-4. PubMed ID: 10073750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
    Sachse C; Brockmöller J; Bauer S; Roots I
    Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population.
    Isaza CA; Henao J; López AM; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Nov; 22(9):695-705. PubMed ID: 11294012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements.
    Gaedigk A; Coetsee C
    Eur J Clin Pharmacol; 2008 May; 64(5):465-75. PubMed ID: 18202841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.
    Bathum L; Skjelbo E; Mutabingwa TK; Madsen H; Hørder M; Brøsen K
    Br J Clin Pharmacol; 1999 Sep; 48(3):395-401. PubMed ID: 10510152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population.
    Griese EU; Zanger UM; Brudermanns U; Gaedigk A; Mikus G; Mörike K; Stüven T; Eichelbaum M
    Pharmacogenetics; 1998 Feb; 8(1):15-26. PubMed ID: 9511177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications.
    Suarez-Kurtz G; Amorim A; Damasceno A; Hutz MH; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Prata MJ; Ribeiro-dos-Santos A; Romano-Silva MA; Teixeira D; Struchiner CJ
    Pharmacogenomics; 2010 Sep; 11(9):1257-67. PubMed ID: 20860466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.